换一批
换一批Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial.
作者：
Meletios A,Dimopoulos [1]
;
Paul G,Richardson [2]
;
Nizar J,Bahlis [3]
;
Sebastian,Grosicki [4]
;
Michele,Cavo [5]
;
Meral,Beksaç [6]
;
Wojciech,Legieć [7]
;
Anna M,Liberati [8]
;
Hartmut,Goldschmidt [9]
;
Andrew,Belch [10]
;
Hila,Magen [11]
;
Alessandra,Larocca [12]
;
Jacob P,Laubach [2]
;
Maria T,Petrucci [13]
;
Donna,Reece [14]
;
Darrell,White [15]
;
María-Victoria,Mateos [16]
;
Ivan,Špička [17]
;
Mihaela,Lazaroiu [18]
;
Jesús,Berdeja [19]
;
Jonathan L,Kaufman [20]
;
Ying-Ming,Jou [21]
;
Alex,Ganetsky [21]
;
Mihaela,Popa McKiver [21]
;
Sagar,Lonial [20]
;
Katja,Weisel [22]
;
ELOQUENT-1 investigators
作者单位：
National and Kapodistrian University of Athens School of Medicine, Athens, Greece. Electronic address: mdimop@med.uoa.gr.
[1]
Dana-Farber Cancer Institute, Boston, MA, USA.
[2]
Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.
[3]
Medical University of Silesia, Katowice, Poland.
[4]
Department of Specialized, Diagnostic, and Experimental Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seràgnoli, Bologna, Italy.
[5]
Ankara University, Ankara, Turkey.
[6]
Center of Oncology of the Lublin Region St Jana z Dukli, Lublin, Poland.
[7]
Universita degli Studi di Perugia, Perugia, Italy.
[8]
University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases, Heidelberg, Germany.
[9]
Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
[10]
Department of Hematology, Chaim Sheba Medical Center Ramat Gan, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
[11]
SSD Clinical Trial in Oncoematologia e Mieloma Multiplo, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
[12]
Sapienza Università di Roma, Rome, Italy.
[13]
Princess Margaret Cancer Centre, Toronto, ON, Canada.
[14]
Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada.
[15]
University Hospital of Salamanca-Instituto de Investigación Biomédica de Salamanca, Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain.
[16]
Charles University and General Teaching Hospital, Prague, Czech Republic.
[17]
Policlinica de Diagnostic Rapid, Brașov, Romania.
[18]
Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN, USA.
[19]
Winship Cancer Institute, Emory University, Atlanta, GA, USA.
[20]
Bristol Myers Squibb, Princeton, NJ, USA.
[21]
University Medical Center of Hamburg-Eppendorf, Hamburg, Germany.
[22]
主题词
老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);地塞米松(Dexamethasone);人类(Humans);男(雄)性(Male);多发性骨髓瘤(Multiple Myeloma)
DOI
10.1016/S2352-3026(22)00103-X
PMID
35550060
发布时间
2022-06-06
- 浏览0
The Lancet. Haematology
The Lancet. Haematology
2022年9卷6期
e403-e414页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
